Quality of generic medicines in South Africa: Perceptions versus Reality - A qualitative study

BMC Health Services Research

Volumn 12, Issue 1, 2012, Pages

  Patel, Aarti ^a,b   Gauld, Robin ^c   Norris, Pauline ^d   Rades, Thomas ^d  

^a Southern African Development Community (SADC)   (Botswana)

^b Hera: Right to Health and Development   (Belgium)

^c UNIVERSITY OF OTAGO   (New Zealand)

^d UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG; GENERIC DRUG;

ADULT; AGED; ARTICLE; ATTITUDE TO HEALTH; BIOAVAILABILITY; CLASSIFICATION; COMPARATIVE STUDY; ECONOMICS; FEMALE; GENERAL PRACTICE; HUMAN; INFORMATION PROCESSING; INTERVIEW; MALE; MIDDLE AGED; NURSE; ORGANIZATION AND MANAGEMENT; PHARMACIST; PHARMACY; PHYSICIAN; PSYCHOLOGICAL ASPECT; QUALITATIVE RESEARCH; SOUTH AFRICA; STANDARD; STATISTICS; THERAPEUTIC EQUIVALENCE;

ADULT; AGED; BIOLOGICAL AVAILABILITY; DRUGS, GENERIC; FAMILY PRACTICE; FEMALE; FOCUS GROUPS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INTERVIEWS AS TOPIC; MALE; MIDDLE AGED; NURSES; PHARMACEUTICAL PREPARATIONS; PHARMACIES; PHARMACISTS; PHYSICIANS; PRIVATE SECTOR; PUBLIC SECTOR; QUALITATIVE RESEARCH; SOUTH AFRICA; THERAPEUTIC EQUIVALENCY;

EID: 84865604061     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-12-297     Document Type: Article

References (24)

1. Resisting medicines: a synthesis of qualitative studies of medicine taking. Pound P, Britten N, Morgan M, et al. Social Science and Medicine 2005 61 1 133 155 10.1016/j.socscimed.2004.11.063 15847968 (Pubitemid 40545066)
2. Encouraging the use of generic medicines: Implications for Transition Economies. King D, Kanavos P, Croatian Medical Journal 2002 43 4 462 469 12187525 (Pubitemid 34976432)
3. Commercial features of placebo and therapeutic efficacy. Waber R, Shiv B, Carmon Z, Ariely D, JAMA 2008 299 9 1016 1017 10.1001/jama.299.9.1016 18319411 (Pubitemid 351347074)
4. Substandard medicines in resource-poor settings: a problem that can no longer be ignored. Caudron J, Ford N, Henkens M, Macé C, Kiddle-Monroe R, Pinel J, Tropical Medicine and International Health 2008 13 8 1062 1072 10.1111/j.1365-3156.2008.02106.x 18631318
5. The global threat of counterfeit drugs: why industry and governments must communicate the dangers. Cockburn R, Newton P, Agyarko E, Akunyili D, White N, PLoS Med 2005 2 4 100 10.1371/journal.pmed.0020100 15755195 (Pubitemid 40721074)
6. Direct to consumer advertising. Mansfield PR, Mintzes B, Richards D, Toop L, British Medical Journal 2005 330 7481 5 6 10.1136/bmj.330.7481.5 15626784 (Pubitemid 40070466)
7. The impact of corporate practices on Health: Implications for Health Policy. Freudenberg N, Galea S, Journal of Public Health Policy 2008 29 1 86 104 10.1057/palgrave.jphp.3200158 18368021
8. Managing drug supply: the selection, procurement, distribution and use of pharmaceuticals, 2nd edition, revised and expanded Connecticut: Kumarian Press, Quick J, Rankin J, O'Connor, 1997
9. Guidelines for field surveys of the quality of medicines: A proposal. Newton P, Lee S, Goodman C, et al. PLoS Medicine 2009 6 3 1000052
10. Knowledge and perceptions of drug quality among drug sellers consumers in Lao PDR. Syhakhang L, Freudenthal S, Tomson G, Wahlström R, Health Policy and Planning 2004 19 6 391 401 10.1093/heapol/czh054 15459164 (Pubitemid 39472142)
11. "This body does not want free medicines": South African consumer perceptions of drug quality. Patel A, Gauld R, Norris P, Rades T, Health Policy and Planning 2010 25 1 61 69 10.1093/heapol/czp039 19726560
12. Improving antibiotic use in low-income countries: an overview of evidence on determinants. Radyowijati A, Haak H, Social Science and Medicine 2003 57 4 733 744 10.1016/S0277-9536(02)00422-7 12821020 (Pubitemid 36765367)
13. A critical review of behavioural issues related to malaria control in sub-Saharan Africa: what contributions have social scientists made? Williams H, Jones C, Social Science and Medicine 2004 59 3 501 523 10.1016/j.socscimed.2003. 11.010 15144761 (Pubitemid 38622296)
14. Department of Health, Standard treatment guidelines and Essential Drugs List Pretoria: DoH, South Africa edition 2003
15. Pharmacopoeial quality of drugs supplied by Nigerian pharmacies. Taylor R, Shakoor O, Behrens R, et al. Lancet 2001 357 9272 1933 1936 10.1016/S0140-6736(00)05065-0 11425415 (Pubitemid 32568335)
16. Antimalarial drug quality in the most severly malariaous parts of Africa-A six country study. Bate R, Coticelli P, Tren R, Attaran A, PLoS One 2008 3 5 2132 10.1371/journal.pone.0002132 18461128 (Pubitemid 352025174)
17. Antiretroviral therapy in Zambia: Colours, "spoiling", "talk" and the meaning of antiretrovirals. Schumaker LL, Bond VA, Social Science and Medicine 2008 67 1 2126 2134 10.1016/j.socscimed.2008.09.006 18952338
18. Anthropological and socio-medical health care research in developing countries. Kroeger A, Social Science and Medicine 1983 17 3 147 161 10.1016/0277-9536(83)90248-4 6836349
19. The Pharmakon Phenomenon: Cultural conceptions of drugs and drug use. Montagne M, Contested Ground: public purpose and private interest in the regulation of prescription drugs Oxford University Press, New York, Davis P, 1996 11 25
20. Social lives of medicines Cambridge: Cambridge University Press, Whyte SR, Geest S, Hardon A, 2002
21. Culture, Illness, and Care: Clinical lessons from anthropologic and cross-cultural research. Kleinman A, Eisenberg L, Good B, The Journal of Lifelong Learning in Psychiatry 2006 iv 140 149
22. South Africa's new national drug policy. Zuma N, Journal of Public Health Policy 1997 18 4 98 105 9170791
23. Health24 (2010), The MCC Mess 2010 http://www.health24.com/printarticle. htm, accessed 31 May 2010.
24. WHO, The world health report: Health Systems Financing: the path to universal coverage Geneva: WHO Press 2010